Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence
Source check: Source checked. Not independent scientific confirmation.
Finding: Among 193 tacrolimus therapeutic-drug-monitoring observations from 123 patients with autoimmune diseases, XGBoost was the best-performing one of 14 tested models for predicting blood concentration (R²=0.54). This retrospective cohort result does not establish improved dosing or clinical outcomes.
Technology: Supervised machine-learning models use patient and treatment variables to predict tacrolimus blood concentration.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Supervised machine-learning models use patient and treatment variables to predict tacrolimus blood concentration.
- Test and result
- Models were trained and assessed using observations from 123 patients; XGBoost reported R² 0.54.
- Limitation / still unknown
- Small retrospective dataset without external validation; dosing utility and patient outcomes were not tested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/articles/PMC8497784
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text, including Methods and Results; first result-bearing version checked against primary publication metadata..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.